Intensive glucose control and cardiovascular outcomes

The Lancet

Volumn 374, Issue 9689, 2009, Pages 522-523

  Lipska, K ^a   Inzucchi, SE ^a   Kosiborod, M ^b   Krumholz, HM ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Saint Luke's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

CARDIOVASCULAR RISK; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; LETTER; MORTALITY; PRIORITY JOURNAL; CARDIOVASCULAR DISEASE; HUMAN; HYPERGLYCEMIA; META ANALYSIS; METHODOLOGY; NOTE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; HUMANS; HYPERGLYCEMIA; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 68349144390     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61479-3     Document Type: Letter

References (5)

1. Ray K.K., Seshasai S.R.K., Wijesuriya S., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 373 (2009) 1765-1772
2. Dormandy J.A., Charbonnel B., Eckland D.J., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
3. Gerstein H.C., Miller M.E., Byington R.P., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
4. Patel A., MacMahon S., Chalmers J., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572
5. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 (2009) 129-139